Antiherpes drug combinations
US7727995B2 · kind B2 · utility
0Cited by
4References
22Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 29, 2004 |
| Grant date | Jun 1, 2010 |
| Priority date | — |
| Expiry date | Sep 28, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K45/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Composition and methods are disclosed that include a synergistic combination of an inhibitor of Herpes simplex virus thymidine kinase, and an antiherpes substance.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.